Calpain-1-dependent degradation of troponin I mutants found in familial hypertrophic cardiomyopathy

By Barta J.   Tóth A.   Jaquet K.   Redlich A.   Édes I.   Papp Z.  

Molecular and Cellular Biochemistry, Vol. 251, Iss. 1-2, 2003-09 ,pp. : 83-88

Springer Publishing Company

Access to resources Recommend Favorite

A mouse model of familial hypertrophic cardiomyopathy caused by a -tropomyosin mutation

By Prabhakar R.   Petrashevskaya N.   Schwartz A.   Aronow B.   Boivin G.P.   Molkentin J.D.   Wieczorek D.F.  

Molecular and Cellular Biochemistry, Vol. 251, Iss. 1-2, 2003-09 ,pp. : 33-42

Springer Publishing Company

Access to resources Recommend Favorite

Phospholamban Gene Mutations Are Not Associated with Hypertrophic Cardiomyopathy in a Northern Greek Population

By Kalemi Theodora   Efthimiadis Georgios   Zioutas Dimitrios   Lambropoulos Alexandros   Mitakidou Anastasia   Giannakoulas Georgios   Vassilikos Vassilios   Karvounis Haralambos   Kotsis Alexandros   Parharidis Georgios   Louridas Georgios  

Biochemical Genetics, Vol. 43, Iss. 11-12, 2005-12 ,pp. : 637-642

Springer Publishing Company

Access to resources Recommend Favorite

A low prevalence of MYH7 / MYBPC3 mutations among Familial Hypertrophic Cardiomyopathy patients in India

By Bashyam Murali  

Molecular and Cellular Biochemistry, Vol. 360, Iss. 1-2, 2012-01 ,pp. : 373-382

Springer Publishing Company

Access to resources Recommend Favorite

Distinct conformational and functional effects of two adjacent pathogenic mutations in cardiac troponin I at the interface with troponin T

By  

FEBS Open Bio, Vol. 5, Iss. 1, 2015-01 ,pp. : 64-75

John Wiley & Sons Inc

Access to resources Recommend Favorite